LAKELAND, Fla., April 30, 2019 /PRNewswire/ -- US Specialty Care, WellDyneRx's wholly-owned specialty pharmacy, was named a finalist in the Annual Patient Choice Awards for a third year in a row. This award recognizes U.S. specialty pharmacies that provide best-in-class customer satisfaction and overall patient care, measured by the patient satisfaction ratings in the ZHI Specialty Pharmacy Patient Satisfaction Survey.
In 2017, US Specialty Care won the inaugural Patient Choice Award in the PBM/Payer Specialty Pharmacy category. The pharmacy subsequently achieved finalist status in both 2018 and 2019. Nick Page, Chief Pharmacy Officer, said, "We're honored to be named a finalist for the Patient Choice Awards again this year. Patient satisfaction is at the heart of everything we do because we know that it translates into increased engagement, higher adherence rates, and improved clinical outcomes. This, in turn, reduces costs for our clients."
To maintain high adherence rates, US Specialty Care recently rolled out customer engagement software, called WellConnect, to deliver personalized healthcare experiences to its patients. This technology enables the pharmacy to enhance its relationship with patients and influence their behaviors. From medication refill reminders to disease information, the WellConnect engagement platform allows pharmacy staff to send secure communications to patients related to their drug therapy.
The Patient Choice Awards™ encompass 2 categories: the pharmacy benefit manager (PBM)/payer award and the non-PBM/payer award, both based on the average net promoter score from quarterly surveys conducted each calendar year. Unlike previous years where the awards ceremony was hosted during the Specialty Pharmacy Summit in Las Vegas, this year's winner will be announced in the fall.
About US Specialty Care
US Specialty Care (USSC) uses unique strategies and formulary options to help contain the cost of specialty products. USSC is widely recognized as a best-of-breed specialty pharmacy and continually yields industry-leading medication adherence rates. USSC has been providing specialty pharmacy services for more than 10 years in all 50 states, with an additional network of distribution pharmacies to serve all of our clients' specialty care needs.
WellDyneRx (www.WellDyneRx.com) is an independent Pharmacy Benefit Manager (PBM) committed to delivering transparent, lowest net cost solutions through integrated data and technology. WellDyneRx members have access to more than 66,000 retail pharmacies across the U.S.; mail order prescription services with the capacity to fulfill more than 15 million prescriptions per year; a wholly-owned award winning specialty pharmacy (www.USSpecialtyCare.com) to focus on specialized drugs; and highly targeted pharmacy programs for Diabetes, Hepatitis C and Opioids to balance optimal clinical outcomes with minimized plan costs.
View original content to download multimedia:http://www.prnewswire.com/news-releases/us-specialty-care-named-finalist-for-2019-patient-choice-awards-third-year-in-a-row-300840699.html